summaryrefslogtreecommitdiffstats
diff options
context:
space:
mode:
authorDavid A. Madore <david+git@madore.org>2020-11-15 14:17:55 +0100
committerDavid A. Madore <david+git@madore.org>2020-11-15 14:17:55 +0100
commitdfd8e476c038d801e6603f797ebf86c69002a687 (patch)
treefe86872d48a9c106c1602669238decc57223b5f3
parent5d2f2da99cff9da896e7b0f19aac9acad0f4ec4f (diff)
downloadcovid19-dfd8e476c038d801e6603f797ebf86c69002a687.tar.gz
covid19-dfd8e476c038d801e6603f797ebf86c69002a687.tar.bz2
covid19-dfd8e476c038d801e6603f797ebf86c69002a687.zip
Link to preprint estimating risks of reinfection.
-rw-r--r--covid19-links.md8
1 files changed, 8 insertions, 0 deletions
diff --git a/covid19-links.md b/covid19-links.md
index b14b3e2..6f43437 100644
--- a/covid19-links.md
+++ b/covid19-links.md
@@ -175,6 +175,14 @@
presented with a total of 1.58 to 8.76 million COVID-19 deaths over
5 years globally.
+* [Assessment of the risk of SARS-CoV-2 reinfection in an intense
+ re-exposure
+ setting](https://www.medrxiv.org/content/10.1101/2020.08.24.20179457v2)
+ (2020-09-28 preprint). Conclusions: “SARS-CoV-2 reinfection can
+ occur but is a rare phenomenon suggestive of a strong protective
+ immunity against reinfection that lasts for at least a few months
+ post primary infection.”
+
* [Covid-19: Do many people have pre-existing
immunity?](https://www.bmj.com/content/370/bmj.m3563) (*British
Medical Journal* feature, 2020-09-17). “It seemed a truth